MEDiC is focusing on cancer drug targets in 3D tumor models using its proprietary CRISPR functional genomics platform.
MEDiC has raised $5.0M in total funding. The most recent round was Corporate Round. The last funding was announced in October 2024.
MEDiC's investors include Sazze Partners, LG, Top Harvest Capital, Hanmi Pharmaceutical, First In Ventures.
MEDiC is headquartered in Palo Alto, United States.
MEDiC is focusing on cancer drug targets in 3D tumor models using its proprietary CRISPR functional genomics platform.
MEDiC is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MEDiC — Funding & Investors." VCBacked, October 14, 2024, https://www.vcbacked.co/company/medic. Accessed August 14, 2026.
VCBacked. (2024). MEDiC — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/medic
{{cite web |title=MEDiC — Funding & Investors |url=https://www.vcbacked.co/company/medic |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated